一种特定于人类的RPGR异型和临床批准的Rho/ROCK抑制剂可改善与RPGR功能障碍相关的缺陷
Muhammad Usman1, Paul Atigbire1, Dennis Kastrati1
1Human Genetics, Medical Faculty-School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, 26129 Oldenburg, Germany.
Molecular therapy. Nucleic acids
|December 1, 2025
概括
视网膜炎染色体GTPase调节器 (RPGR) 基因中的致病变异导致X链接的RP. 人类特异性的RPGR-s14/15异型对状细胞和状细胞完整性至关重要,而ripasudil治疗显示出治疗潜力.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 视网膜色素炎GTPase调节器 (RPGR) 基因中的致病变体是X链接视网膜色素炎 (RP) 的主要原因,这种疾病会导致光感受器退化.
- RPGR功能障碍与状细胞结构和行为动态的缺陷有关,这对光受体功能至关重要.
- 人类特异性RPGR异形 (RPGRs14/15) 的功能尚不清楚,尽管迫切需要RPGR相关的RP治疗.
研究的目的:
- 调查RPGR异型,特别是RPGRs14/15在维持状细胞完整性和行动蛋白循环中的作用.
- 确定与RPGR相关的RP的潜在治疗策略.
主要方法:
- 生成的RPGR突变hTERT-RPE1细胞系缺乏所有RPGR异型 (RPGR_KO).
- 在RPGR_KO细胞和仅表达RPGRs的细胞中评估了状结构 (长度,细分) 和行为动力学14/15.5.
- 使用的药理学药剂:细胞素D (CytoD) 干扰动素聚合和ripasudil (Rho/ROCK抑制剂) 测试救援效应.
主要成果:
- 在RPGR_KO细胞中,所有RPGR异型的损失导致了显著的状细胞缺陷,并破坏了actin的循环.
- 仅表达人类特异性RPGRs14/15异型的细胞在很大程度上阻止了这些缺陷,突出了其关键作用.
- 活性蛋白聚合物的药理学干扰模仿了RPGR缺陷表型.
- 里帕苏迪尔治疗有效地挽救了RPGR_KO细胞中的状细胞和状细胞相关缺陷,没有明显的副作用.
结论:
- 特定于人类的RPGRs14/15异型在维持状细胞完整性和动蛋白动态方面发挥着至关重要的作用.
- 里帕苏迪尔在治疗RPGR相关的视网膜退化方面具有显著的治疗潜力,通过解决状细胞和与动蛋白相关的缺陷.
相关概念视频
Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
439
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
439
Rab Proteins
4.9K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.9K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K


